Loading...
Small Molecule Inhibitors Targeting the ‘Achilles’ Heel of Androgen Receptor Activity
Androgen ablation therapy remains the gold standard for the treatment of advanced prostate cancer, but unfortunately, it is not curative and eventually the disease will return as lethal castration-resistant prostate cancer (CRPC). There is mounting evidence supporting the concept that development of...
Saved in:
| Main Author: | |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
2011
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3132148/ https://ncbi.nlm.nih.gov/pubmed/21285252 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN_10-3398 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|